Supplemental Guarantor Financial Information (Condensed Consolidating Statement of Cash Flows) (Details) - USD ($)	3 Months Ended												12 Months Ended
	Jan. 30, 2016	Oct. 31, 2015	Aug. 01, 2015	May. 02, 2015	Jan. 31, 2015	Nov. 01, 2014	Aug. 02, 2014	May. 03, 2014	Feb. 01, 2014	Nov. 02, 2013	Aug. 03, 2013	May. 04, 2013	Jan. 30, 2016	Jan. 31, 2015	Feb. 01, 2014
Net Cash Provided by (Used for) Operating Activities													$ 1,869,000,000	$ 1,786,000,000	$ 1,248,000,000
Investing Activities
Capital Expenditures													(727,000,000)	(715,000,000)	(691,000,000)
Proceeds from Sale of Other Assets, Investing Activities													196,000,000	0	0
Return of Capital													0	0	46,000,000
Proceeds from Sale of Equity Method Investments													85,000,000	0	0
Payments to Acquire Marketable Securities													(60,000,000)	0	0
Proceeds from Sale and Maturity of Marketable Securities													50,000,000	0	0
Other Investing Activities													13,000,000	16,000,000	(10,000,000)
Net Cash Provided by (Used for) Investing Activities													(443,000,000)	(699,000,000)	(655,000,000)
Financing Activities
Proceeds from Long-term Debt, Net of Issuance Costs													988,000,000	0	495,000,000
Borrowings from Revolving Facilities													7,000,000	5,000,000	290,000,000
Repayments on Revolving Facilities													0	(5,000,000)	(290,000,000)
Payments of Long-term Debt													0	(213,000,000)	0
Repurchase of Common Stock													(483,000,000)	(87,000,000)	(60,000,000)
Dividends Paid	$ (145,000,000)	$ (146,000,000)	$ (146,000,000)	$ (734,000,000)	$ (100,000,000)	$ (100,000,000)	$ (99,000,000)	$ (392,000,000)	$ (88,000,000)	$ (87,000,000)	$ (87,000,000)	$ (87,000,000)	(1,171,000,000)	(691,000,000)	(349,000,000)
Excess Tax Benefits from Share-based Compensation													70,000,000	43,000,000	36,000,000
Net Financing Activities and Advances to/from Consolidated Affiliates													0	0	0
Proceeds From Exercise of Stock Options													33,000,000	35,000,000	32,000,000
Proceeds from (Payments for) Other Financing Activities													(2,000,000)	(6,000,000)	0
Net Cash Provided by (Used for) Financing Activities													(558,000,000)	(919,000,000)	154,000,000
Effects of Exchange Rate Changes on Cash													(1,000,000)	(6,000,000)	(1,000,000)
Net Increase (Decrease) in Cash and Cash Equivalents													867,000,000	162,000,000	746,000,000
Cash and Cash Equivalents, Beginning of Year				1,681,000,000				1,519,000,000				773,000,000	1,681,000,000	1,519,000,000	773,000,000
Cash and Cash Equivalents, End of Year	2,548,000,000				1,681,000,000				1,519,000,000				2,548,000,000	1,681,000,000	1,519,000,000
Third Party Sourcing Business [Member]
Investing Activities
Return of Capital															46,000,000
L Brands, Inc. [Member]
Net Cash Provided by (Used for) Operating Activities													(322,000,000)	(333,000,000)	(302,000,000)
Investing Activities
Capital Expenditures													0	0	0
Proceeds from Sale of Other Assets, Investing Activities													0
Return of Capital															0
Proceeds from Sale of Equity Method Investments													0
Payments to Acquire Marketable Securities													0
Proceeds from Sale and Maturity of Marketable Securities													0
Other Investing Activities													0	0	0
Net Cash Provided by (Used for) Investing Activities													0	0	0
Financing Activities
Proceeds from Long-term Debt, Net of Issuance Costs													988,000,000		495,000,000
Borrowings from Revolving Facilities													0	0	290,000,000
Repayments on Revolving Facilities														0	(290,000,000)
Payments of Long-term Debt														(213,000,000)
Repurchase of Common Stock													(483,000,000)	(87,000,000)	(60,000,000)
Dividends Paid													(1,171,000,000)	(691,000,000)	(349,000,000)
Excess Tax Benefits from Share-based Compensation													0	0	0
Net Financing Activities and Advances to/from Consolidated Affiliates													955,000,000	1,295,000,000	184,000,000
Proceeds From Exercise of Stock Options													33,000,000	35,000,000	32,000,000
Proceeds from (Payments for) Other Financing Activities													0	6,000,000
Net Cash Provided by (Used for) Financing Activities													322,000,000	333,000,000	302,000,000
Effects of Exchange Rate Changes on Cash													0	0	0
Net Increase (Decrease) in Cash and Cash Equivalents													0	0	0
Cash and Cash Equivalents, Beginning of Year				0				0				0	0	0	0
Cash and Cash Equivalents, End of Year	0				0				0				0	0	0
Guarantor Subsidiaries
Net Cash Provided by (Used for) Operating Activities													1,835,000,000	1,677,000,000	1,323,000,000
Investing Activities
Capital Expenditures													(506,000,000)	(486,000,000)	(475,000,000)
Proceeds from Sale of Other Assets, Investing Activities													0
Return of Capital															0
Proceeds from Sale of Equity Method Investments													1,000,000
Payments to Acquire Marketable Securities													(50,000,000)
Proceeds from Sale and Maturity of Marketable Securities													50,000,000
Other Investing Activities													0	(1,000,000)	0
Net Cash Provided by (Used for) Investing Activities													(505,000,000)	(487,000,000)	(475,000,000)
Financing Activities
Proceeds from Long-term Debt, Net of Issuance Costs													0		0
Borrowings from Revolving Facilities													0	0	0
Repayments on Revolving Facilities														0	0
Payments of Long-term Debt														0
Repurchase of Common Stock													0	0	0
Dividends Paid													0	0	0
Excess Tax Benefits from Share-based Compensation													62,000,000	37,000,000	31,000,000
Net Financing Activities and Advances to/from Consolidated Affiliates													(662,000,000)	(1,118,000,000)	57,000,000
Proceeds From Exercise of Stock Options													0	0	0
Proceeds from (Payments for) Other Financing Activities													(2,000,000)	0
Net Cash Provided by (Used for) Financing Activities													(602,000,000)	(1,081,000,000)	88,000,000
Effects of Exchange Rate Changes on Cash													0	0	0
Net Increase (Decrease) in Cash and Cash Equivalents													728,000,000	109,000,000	936,000,000
Cash and Cash Equivalents, Beginning of Year				1,462,000,000				1,353,000,000				417,000,000	1,462,000,000	1,353,000,000	417,000,000
Cash and Cash Equivalents, End of Year	2,190,000,000				1,462,000,000				1,353,000,000				2,190,000,000	1,462,000,000	1,353,000,000
Non-Guarantor Subsidiaries
Net Cash Provided by (Used for) Operating Activities													356,000,000	442,000,000	227,000,000
Investing Activities
Capital Expenditures													(221,000,000)	(229,000,000)	(216,000,000)
Proceeds from Sale of Other Assets, Investing Activities													196,000,000
Return of Capital															46,000,000
Proceeds from Sale of Equity Method Investments													84,000,000
Payments to Acquire Marketable Securities													(10,000,000)
Proceeds from Sale and Maturity of Marketable Securities													0
Other Investing Activities													13,000,000	17,000,000	(10,000,000)
Net Cash Provided by (Used for) Investing Activities													62,000,000	(212,000,000)	(180,000,000)
Financing Activities
Proceeds from Long-term Debt, Net of Issuance Costs													0		0
Borrowings from Revolving Facilities													7,000,000	5,000,000	0
Repayments on Revolving Facilities														(5,000,000)	0
Payments of Long-term Debt														0
Repurchase of Common Stock													0	0	0
Dividends Paid													0	0	0
Excess Tax Benefits from Share-based Compensation													8,000,000	6,000,000	5,000,000
Net Financing Activities and Advances to/from Consolidated Affiliates													(293,000,000)	(177,000,000)	(241,000,000)
Proceeds From Exercise of Stock Options													0	0	0
Proceeds from (Payments for) Other Financing Activities													0	0
Net Cash Provided by (Used for) Financing Activities													(278,000,000)	(171,000,000)	(236,000,000)
Effects of Exchange Rate Changes on Cash													(1,000,000)	(6,000,000)	(1,000,000)
Net Increase (Decrease) in Cash and Cash Equivalents													139,000,000	53,000,000	(190,000,000)
Cash and Cash Equivalents, Beginning of Year				219,000,000				166,000,000				356,000,000	219,000,000	166,000,000	356,000,000
Cash and Cash Equivalents, End of Year	358,000,000				219,000,000				166,000,000				358,000,000	219,000,000	166,000,000
Eliminations
Net Cash Provided by (Used for) Operating Activities													0	0	0
Investing Activities
Capital Expenditures													0	0	0
Proceeds from Sale of Other Assets, Investing Activities													0
Return of Capital															0
Proceeds from Sale of Equity Method Investments													0
Payments to Acquire Marketable Securities													0
Proceeds from Sale and Maturity of Marketable Securities													0
Other Investing Activities													0	0	0
Net Cash Provided by (Used for) Investing Activities													0	0	0
Financing Activities
Proceeds from Long-term Debt, Net of Issuance Costs													0		0
Borrowings from Revolving Facilities													0	0	0
Repayments on Revolving Facilities														0	0
Payments of Long-term Debt														0
Repurchase of Common Stock													0	0	0
Dividends Paid													0	0	0
Excess Tax Benefits from Share-based Compensation													0	0	0
Net Financing Activities and Advances to/from Consolidated Affiliates													0	0	0
Proceeds From Exercise of Stock Options													0	0	0
Proceeds from (Payments for) Other Financing Activities													0	0
Net Cash Provided by (Used for) Financing Activities													0	0	0
Effects of Exchange Rate Changes on Cash													0	0	0
Net Increase (Decrease) in Cash and Cash Equivalents													0	0	0
Cash and Cash Equivalents, Beginning of Year				$ 0				$ 0				$ 0	0	0	0
Cash and Cash Equivalents, End of Year	$ 0				$ 0				$ 0				$ 0	$ 0	$ 0